Wednesday, July 29, 2026

HomeHealth NewsScientists propose CDK2 enzyme as new target for cancer therapy

Scientists propose CDK2 enzyme as new target for cancer therapy

- Advertisement -

Co-expression of P16INK4A and cyclin E1 in breast cancer patients. Credit: Nature Communications (2025). DOI: 10.1038/s41467-025-56674-4

An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic resistance to common breast cancer drugs—including a class of targeted…

Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed